Cabaletta Bio, Inc. ( CABA) - Stock Earnings
CABA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
CABA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -44.9 million USD | — USD |
| 2025Q4 | -41.9 million USD | — USD |
| 2026Q1 | -43.5 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CABA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -67.7 million USD | — USD |
| 2024 | -115.9 million USD | — USD |
| 2025 | -167.9 million USD | — USD |
| 2026 Est. | — | — |
CABA
Price: $2.69
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 489500
Market Capitalization: 520.1 million